Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 44-48

  Yu, Shan ^a,b   Wong, Siu Ling ^a   Lau, Chi Wai ^a   Huang, Yu ^a   Yu, Cheuk Man ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Akt; Coronary artery endothelial cell; ENOS; NO; OxLDL

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ANGIOGENESIS; ARTERY ENDOTHELIUM; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 79953162175     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.096     Document Type: Article

References (35)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320:915-924.
2. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J. Lipid Res. 2009, 50(Suppl):S376-S381.
3. Fraley A.E., Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr. Opin. Lipidol. 2006, 17:502-529.
4. Verhoye E., Langlois M.R. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?. Clin. Chem. Lab. Med. 2009, 47:128-137.
5. Victor V.M., Rocha M., Sola E., Banuls C., Garcia-Malpartida K., Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des. 2009, 15:2988-3002.
6. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109:III27-III32.
7. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 1999, 274:32512-32519.
8. Gardner G., Banka C.L., Roberts K.A., Mullick A.E., Rutledge J.C. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17 beta-estradiol. Arterioscler. Thromb. Vasc. Biol. 1999, 19:854-861.
9. Murugesan G., Chisolm G.M., Fox P.L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 1993, 120:1011-1019.
10. Li D., Yang B., Mehta J.L. Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am. J. Physiol. 1998, 275:H568-H576.
11. Chouinard J.A., Grenier G., Khalil A., Vermette P. Oxidized-LDL induce morphological changes and increase stiffness of endothelial cells. Exp. Cell Res. 2008, 314:3007-3016.
12. Wang D.Y., Yang V.C., Chen J.K. Oxidized LDL inhibits vascular endothelial cell morphogenesis in culture. In Vitro Cell. Dev. Biol. Anim. 1997, 33:248-255.
13. Thorne S.A., Abbot S.E., Winyard P.G., Blake D.R., Mills P.G. Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart 1996, 75:11-16.
14. Zhu W., Roma P., Pirillo A., Pellegatta F., Catapano A.L. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler. Thromb. Vasc. Biol. 1996, 16:1104-1111.
15. Stielow C., Catar R.A., Muller G., Wingler K., Scheurer P., Schmidt H.H., Morawietz H. Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem. Biophys. Res. Commun. 2006, 344:200-205.
16. Dandapat A., Hu C., Sun L., Mehta J.L. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2435-2442.
17. Seibold S., Schurle D., Heinloth A., Wolf G., Wagner M., Galle J. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA. J. Am. Soc. Nephrol. 2004, 15:3026-3034.
18. Vanhoutte P.M., Shimokawa H., Tang E.H., Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. (Oxf) 2009, 196:193-222.
19. Papapetropoulos A., Garcia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 1997, 100:3131-3139.
20. Shizukuda Y., Tang S., Yokota R., Ware J.A. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ. Res. 1999, 85:247-256.
21. Ingueneau C., Huynh-Do U., Thiers J.C., Negre-Salvayre A., Salvayre R., Vindis C. Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. Biochem. Biophys. Res. Commun. 2008, 369:889-893.
22. C.Y. Yuen, W.T. Wong, X.Y. Tian, S.L. Wong, C.W. Lau, J. Yu, B. Tomlinson, X. Yao, Y. Huang, Telmisartan inhibits vasoconstriction via PPAR{gamma}-dependent expression and activation of endothelial nitric oxide synthase, Cardiovasc. Res. (2010) [Epub ahead of print].
23. Yoshida H., Kisugi R. Mechanisms of LDL oxidation. Clin. Chim. Acta 2010, 411:1875-1882.
24. Duong M., Petit J.M., Martha B., Galland F., Piroth L., Walldner A., Grappin M., Buisson M., Duvillard L., Chavanet P., Portier H. Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy. HIV Clin. Trials 2006, 7:41-47.
25. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., Collen D., Muls E., Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2001, 21:844-848.
26. Holvoet P., Jenny N.S., Schreiner P.J., Tracy R.P., Jacobs D.R. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2007, 194:245-252.
27. Webster K.A. Therapeutic angiogenesis for coronary artery disease: clinical trials of proteins, Plasmids, adenovirus and stem cells. Future Cardiol. 2005, 1:99-109.
28. Virmani R., Kolodgie F.D., Burke A.P., Finn A.V., Gold H.K., Tulenko T.N., Wrenn S.P., Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2054-2061.
29. Fuster V., Moreno P.R., Fayad Z.A., Corti R., Badimon J.J. Atherothrombosis and high-risk plaque. Part I. Evolving concepts. J. Am. Coll. Cardiol. 2005, 46:937-954.
30. Sluimer J.C., Daemen M.J. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J. Pathol. 2009, 218:7-29.
31. Bochkov V.N., Philippova M., Oskolkova O., Kadl A., Furnkranz A., Karabeg E., Afonyushkin T., Gruber F., Breuss J., Minchenko A., Mechtcheriakova D., Hohensinner P., Rychli K., Wojta J., Resink T., Erne P., Binder B.R., Leitinger N. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ. Res. 2006, 99:900-908.
32. Moncada S., Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329:2002-2012.
33. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 1998, 101:731-736.
34. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J.F., Fishman M.C., Huang P.L., Isner J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 1998, 101:2567-2578.
35. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.